CIK 0001745999 · Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- 4 Grant or award Chief Medical Officer acquired 31,750 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 31,750 shares (grant or award)
- 4 Grant or award President acquired 40,000 shares (grant or award)
- 4 Planned sale CEO sold 50,000 shares at an average $22.57 ($1,128,315)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Agreement ended
- 4 Planned sale President sold 35,000 shares at $32.00 ($1,120,042)
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Material agreement · Results of operations · New debt or obligation
- 8-K Event Material agreement
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Executive or director change
Page 3 of 26 · 514 filings